Advertisement
Exposure to opioid maintenance treatment in the womb does not seem to cause additional harm to newborns

Prenatal Exposure to OMT Does Not Worsen Neonatal Outcomes

0
Growth parameters similar to those for newborns of women with opioid use disorders during pregnancy
Polyunsaturated fatty acids have little to no effect on the prevention or treatment of type 2 diabetes mellitus

Polyunsaturated Fatty Acids Have Little, No Impact on Diabetes

0
Review indicates little to no effect on newly diagnosed diabetes, measures of glucose metabolism
From 2006 to 2016

Prices Spike for Drugs Used to Treat Multiple Sclerosis

0
2006-2016 Medicare claims show 10.2-fold, 7.2-fold hikes in pharmaceutical, out-of-pocket spending
For patients with early rheumatoid arthritis and high disease activity

Combo Tx May Improve Disease Control for Some in Early RA

0
Improved disease control, remission, functional capacity for TNF or non-TNF plus methotrexate
The number of marijuana growers allowed to produce the drug for U.S. government-approved research will be expanded from one to 34

DEA to Approve Dozens More Growers for Marijuana Research

0
Added sites will provide researchers with greater variety of marijuana to study
Purdue Pharma

OxyContin Maker Offers Up to $12 Billion to Settle Opioid Claims

0
Potential deal has been discussed by lawyers representing Purdue and at least 10 state attorneys general
Postprescription audit and review is a feasible and effective strategy for antimicrobial stewardship in community hospitals

PostRx Antimicrobial Stewardship Feasible in Community Hospitals

0
Postprescription audit and review effective in settings with limited resources, expertise
Recall of electronic nicotine delivery systems (ENDS) marketing at retail stores is associated with increased subsequent ENDS initiation among youth and young adults

In-Store E-Cigarette Marketing Influences Use in Young People

0
Retail store electronic nicotine delivery systems marketing recall tied to increased odds of initiation
There is an increased risk for gallbladder- or biliary tract-related events among patients with type 2 diabetes taking liraglutide versus placebo

Liraglutide Ups Risk for Gallbladder, Biliary Tract Events

0
Findings consistent for gallbladder stones, cholecystitis with/without gallbladder stones, biliary obstruction
Survivors of childhood cancer have an increased risk for all subtypes of cardiovascular disease

Risk for Cardiovascular Disease Greater for Childhood Cancer Survivors

0
Exposure to ≥250 mg/m² doxorubicin-equivalent anthracycline chemo tied to risk for CVD, heart failure